These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3300375)

  • 1. Effect of bromocriptine on affect and libido in hyperprolactinemia.
    Koppelman MC; Parry BL; Hamilton JA; Alagna SW; Loriaux DL
    Am J Psychiatry; 1987 Aug; 144(8):1037-41. PubMed ID: 3300375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bromocriptine on antipsychotic drug-induced hyperprolactinemia: eight-week randomized, single-blind, placebo-controlled, multicenter study.
    Lee MS; Song HC; An H; Yang J; Ko YH; Jung IK; Joe SH
    Psychiatry Clin Neurosci; 2010 Feb; 64(1):19-27. PubMed ID: 19968833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of bromocriptine treatment on sexual functioning and depressive symptoms in women with mild hyperprolactinemia.
    Krysiak R; Szkróbka W; Okopień B
    Pharmacol Rep; 2018 Apr; 70(2):227-232. PubMed ID: 29475005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of distress in hyperprolactinemia with bromocriptine.
    Buckman MT; Kellner R
    Am J Psychiatry; 1985 Feb; 142(2):242-4. PubMed ID: 3882004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic-associated hyperprolactinemia. Can it be treated with bromocriptine?
    Smith S
    J Reprod Med; 1992 Aug; 37(8):737-40. PubMed ID: 1359137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine agonists for reducing depression associated with hyperprolactinemia.
    Mattox JH; Buckman MT; Bernstein J; Pathak D; Kellner R
    J Reprod Med; 1986 Aug; 31(8):694-8. PubMed ID: 3772890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperprolactinemia in oligospermic Nigerian males: effect of bromocriptine treatment.
    Modebe O
    Int J Fertil Menopausal Stud; 1994; 39(2):95-9. PubMed ID: 8012447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group.
    Webster J; Piscitelli G; Polli A; Ferrari CI; Ismail I; Scanlon MF
    N Engl J Med; 1994 Oct; 331(14):904-9. PubMed ID: 7915824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of two dopaminergic drugs on menstrual function and psychological state in hyperprolactinemia.
    Lappöhn RE; van de Wiel HB; Brownell J
    Fertil Steril; 1992 Aug; 58(2):321-7. PubMed ID: 1353028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia.
    Yuan HN; Wang CY; Sze CW; Tong Y; Tan QR; Feng XJ; Liu RM; Zhang JZ; Zhang YB; Zhang ZJ
    J Clin Psychopharmacol; 2008 Jun; 28(3):264-370. PubMed ID: 18480682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between a slow-release oral preparation of bromocriptine and regular bromocriptine in patients with hyperprolactinemia: a double blind, double dummy study.
    Moro M; Maraschini C; Toja P; Masala A; Alagna S; Rovasio PP; Ginanni A; Lancranjan I; Cavagnini F
    Horm Res; 1991; 35(3-4):137-41. PubMed ID: 1806467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin-lowering effect of acute and once weekly repetitive oral administration of cabergoline at two dose levels in hyperprolactinemic patients.
    Mattei AM; Ferrari C; Baroldi P; Cavioni V; Paracchi A; Galparoli C; Romano C; Spellecchia D; Gerevini G; Crosignani PG
    J Clin Endocrinol Metab; 1988 Jan; 66(1):193-8. PubMed ID: 3275684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of therapeutic outcomes of polycystic ovary syndrome patients with hyperprolactinemia].
    Shi YH; Sheng Y; Chen ZJ; Yan JH; Gao Q; Liu H; Ma ZX
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):251-3. PubMed ID: 18843962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of fenofibrate on cardiometabolic risk factors in young women with and without hyperprolactinemia.
    Krysiak R; Szkróbka W; Okopień B
    Pharmacol Rep; 2019 Feb; 71(1):61-66. PubMed ID: 30469130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of vaginal bromocriptine in treating women with hyperprolactinemia.
    Kletzky OA; Vermesh M
    Fertil Steril; 1989 Feb; 51(2):269-72. PubMed ID: 2912773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy, tolerability and safety of Parlodel LAR versus Parlodel in hyperprolactinemia.
    Bolanowski M; Milewicz A; Bohdanowicz-Pawlak A; Bednarek-Tupikowska G; Jedrzejak JA; Lancranjan I
    Endokrynol Pol; 1993; 44(4):467-76. PubMed ID: 8055815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromocriptine improves reduced libido and potency in men receiving maintenance hemodialysis.
    Muir JW; Besser GM; Edwards CR; Rees LH; Cattell WR; Ackrill P; Baker LR
    Clin Nephrol; 1983 Dec; 20(6):308-14. PubMed ID: 6357576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and hormonal response to short-term intermittent versus continuous oral bromocriptine in hyperprolactinemic women.
    Parra A; Crespo G; Coria I; Espinosa de los Monteros A
    Int J Fertil Menopausal Stud; 1995; 40(2):96-101. PubMed ID: 7599666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study on effect of Bushen Tiaogan Lianru recipe on hyperprolactinemia].
    Liu J; Wang J; Chen X
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1998 Mar; 18(3):142-4. PubMed ID: 11367660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of CV 205-502 in hyperprolactinaemic patients intolerant of bromocriptine.
    Newman CB; Hurley AM; Kleinberg DL
    Clin Endocrinol (Oxf); 1989 Oct; 31(4):391-400. PubMed ID: 2576397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.